Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Attributes for a discrete-choice experiment on preferences of patients for oncology pharmacy consultations.
Damerval M, Bennani M, Rioufol C, Omrani S, Riboulet M, Etienne-Selloum N, Saint-Ghislain A, Leenhardt F, Schmitt A, Simon N, Clairet AL, Meurisse A; French Implication Expert Panel; Nerich V. Damerval M, et al. Among authors: clairet al. Support Care Cancer. 2024 Apr 30;32(5):318. doi: 10.1007/s00520-024-08517-z. Support Care Cancer. 2024. PMID: 38687392
Enhancing collaboration between geriatricians, oncologists, and pharmacists to optimize medication therapy in older adults with cancer: A position paper from SOFOG-SFPO.
Herledan C, Toulemonde A, Clairet AL, Boulin M, Falandry C, Decker L, Rioufol C, Bayle A, Bertrand N. Herledan C, et al. Among authors: clairet al. Crit Rev Oncol Hematol. 2023 Oct;190:104117. doi: 10.1016/j.critrevonc.2023.104117. Epub 2023 Sep 1. Crit Rev Oncol Hematol. 2023. PMID: 37660933 Review.
Oral therapy adherence and satisfaction in patients with multiple myeloma.
Solano M, Daguindau E, Faure C, Loriod P, Pain C, Maes AC, Marguet P, Kroemer M, Rumpler A, Fontan J, Deconinck E, Limat S, Clairet AL. Solano M, et al. Among authors: clairet al. Ann Hematol. 2021 Jul;100(7):1803-1813. doi: 10.1007/s00277-021-04543-7. Epub 2021 May 3. Ann Hematol. 2021. PMID: 33938996
COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity.
Kroemer M, Spehner L, Vettoretti L, Bouard A, Eberst G, Pili Floury S, Capellier G, Lepiller Q, Orillard E, Mansi L, Clairet AL, Westeel V, Limat S, Dubois M, Malinowski L, Bohard L, Borg C, Chirouze C, Bouiller K. Kroemer M, et al. Among authors: clairet al. J Infect. 2021 Feb;82(2):282-327. doi: 10.1016/j.jinf.2020.08.036. Epub 2020 Aug 25. J Infect. 2021. PMID: 32853599 Free PMC article.
Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO - PRODIGE 82).
Vienot A, Jacquin M, Rebucci-Peixoto M, Pureur D, Ghiringhelli F, Assenat E, Hammel P, Rosmorduc O, Stouvenot M, Allaire M, Bouattour M, Regnault H, Fratte S, Raymond E, Soularue E, Husson-Wetzel S, Di Martino V, Muller A, Clairet AL, Fagnoni-Legat C, Adotevi O, Meurisse A, Vernerey D, Borg C. Vienot A, et al. Among authors: clairet al. BMC Cancer. 2023 Jul 29;23(1):710. doi: 10.1186/s12885-023-11065-0. BMC Cancer. 2023. PMID: 37516867 Free PMC article. Clinical Trial.
24 results